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Abstract: Adipose tissue is a promising source of mesenchymal stem cells. Their potential to
differentiate and regenerate other types of tissues may be affected by several factors. This may
be due to in vitro cell-culture conditions, especially the supplementation with antibiotics. The aim of
our study was to evaluate the effects of a penicillin-streptomycin mixture (PS), amphotericin B (AmB),
a complex of AmB with copper (II) ions (AmB-Cu2+) and various combinations of these antibiotics
on the proliferation and differentiation of adipose-derived stem cells in vitro. Normal human
adipose-derived stem cells (ADSC, Lonza) were routinely maintained in a Dulbecco’s Modified
Eagle Medium (DMEM) that was either supplemented with selected antibiotics or without antibiotics.
The ADSC that were used for the experiment were at the second passage. The effect of antibiotics on
proliferation was analyzed using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
(MTT) and sulforhodamine-B (SRB) tests. Differentiation was evaluated based on Alizarin Red
staining, Oil Red O staining and determination of the expression of ADSC, osteoblast and adipocyte
markers by real-time RT-qPCR. The obtained results indicate that the influence of antibiotics on
adipose-derived stem cells depends on the duration of exposure and on the combination of applied
compounds. We show that antibiotics alter the proliferation of cells and also promote natural
osteogenesis, and adipogenesis, and that this effect is also noticeable in stimulated osteogenesis.
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1. Introduction
Adipose tissue is an excellent source of adult stem cells, which are called adipose-derived stem
cells (ADSC) [1]. They hold great promise in cell replacement therapies, and studies demonstrated
their properties in the regeneration of bones, joints or cardiomyocytes in vivo and in vitro [2–4].
The cell harvesting procedure is minimally invasive and it permits a large number of cells with strong
proliferative ability and multidifferentiation potential to be extracted and then injected into bone,
cartilage and adipose tissues. The ADSC are usually extracted from the SVF (stromal vascular fraction)
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that is obtained from adipose tissue and they have a fibroblast-like morphology and adhere to culture
dishes [3,5–7].
Antibiotics are extremely important in transplantation and regenerative medicine procedures.
Isolation and cultivation of adipose-derived stem cells usually involves the presence of the
penicillin-streptomycin mixture [2,5,8,9] although some studies have also suggested using
amphotericin B because of its widespread antifungal activity [10,11]. Gentamycin is also commonly
used in cell cultures, although a penicillin-streptomycin (PS) mixture is the only one that is
recommended by the American Type Culture Collection (ATCC) [12]. Protective/preventive antibiotic
therapy improves the success/safety of transplantation procedures [10]. To minimize complications,
stem cells must be isolated and cultured under the optimal conditions for a particular cell type, in order
to use them in transplantology. They have to be maintained in an undifferentiated state to preserve
their self-renewal potential. Unfortunately, it has been suggested that the antibiotics in a cell culture
may change the regenerative potential and other biologic properties in many types of cells [13].
One of the most effective antifungal compounds is amphotericin B (AmB), a polyene antimycotic
drug that belongs to the macrolides [14,15]. Due to the cytotoxic effect on human cells, its usefulness
in stem cells cultivation may be problematic, however, there are available less toxic forms of the AmB.
One of them is complex of amphotericin B with copper (II) ions (AmB-Cu2+), which was reported to be
less toxic to animal cells and more potent in combating fungal infections [16–19]. Thus, replacing AmB
with its modified form AmB-Cu2+ in stem cell culture may favorably affect their ability to proliferate
and differentiate.
The influence of penicillin, streptomycin, amphotericin B and AmB-Cu2+ on stem cells, especially
related to their impact on ADSC, has not been studied so far. The object of the present study was to
evaluate the influence of these antibiotics on the growth and differentiation potential of ADSC. In the
first step the influence of antibiotics and their combinations on stem cells viability was tested. Next,
the potential of adipogenesis and osteogenesis promotion by antibiotics in the absence of dedicated
differentiation factors was assessed (in basic medium). Obtained results have prompted us to the
evaluation of the influence of antibiotics and their combinations on differentiation into osteoblasts in
the dedicated osteogenesis medium.
2. Results
2.1. Effect of Antibiotics on Cell Viability in the ADSC
The viability of cells was assessed indirectly by the measurement of total cellular protein content in
ADSC after 24, 48 and 72 h of incubation with antibiotics. Cells treated for 24 h with AmB, AmB-Cu2+,
PS-AmB and PS-AmB-Cu2+ showed a statistically significant decrease of viability comparing to
the control (p = 0.0001, p = 0.0021, p = 0.0002, and p = 0.0001, respectively) (Figure 1A). Moreover,
statistically significant decreased viability was also observed for cells treated with AmB, PS-AmB and
PS-AmB-Cu2+ comparing to the PS-treated cells (p = 0.0226, p = 0.0431, p = 0.0217, respectively).
After 48 h, cells treated with AmB-Cu2+ showed higher viability than the control (p = 0.0004),
AmB (p = 0.0001), PS- (p = 0.0004), PS-AmB- (p = 0.0371) and PS-AmB-Cu2+-treated cells (p = 0.0001)
(Figure 1B). PS-AmB caused higher cell viability comparing to AmB (p = 0.0082) and PS-AmB-Cu2+
(p = 0.0280).
Seventy-two hours of incubation caused a significant decrease in the viability of cells exposed
to AmB-Cu2+ and PS-AmB-Cu2+, comparing to the control (p = 0.0145, p = 0.0206), PS (p = 0.0313,
p = 0.0144), and AmB groups (p = 0.0001, p = 0.0002) (Figure 1C). AmB treatment increased the cell
viability in comparison to PS-AmB group (p = 0.0104)
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Figure 1. Cell viability based on the measurement of total cellular protein content after exposure to 
the tested antibiotics and their combinations for 24 (A), 48 (B) and 72 h (C). The bars represent the 
means ± standard deviation (SD) of the percentages of the control cell viability (100%); analysis of 
variance (ANOVA) with the Tukey post hoc test, * p < 0.05 vs. control, # p < 0.05 vs. PS, ^ p < 0.05 vs. 
AmB-Cu2+, + p < 0.05 vs. AmB, $ p < 0.05 vs. PS-AmB-Cu2+. 
  
Figure 1. Cell viability based on the measurement of total cellular protein content after exposure to the
tested antibiotics and their combinations for 24 (A), 48 (B) and 72 h (C). The bars represent the means
± standard deviation (SD) of the percentages of the control cell viability (100%); analysis of variance
(ANOVA) with the Tukey post hoc test, * p < 0.05 vs. control, # p < 0.05 vs. PS, ˆ p < 0.05 vs. AmB-Cu2+,
+ p < 0.05 vs. AmB, $ p < 0.05 vs. PS-AmB-Cu2+.
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2.2. Effect of Antibiotics on the Mitochondrial Oxidative Activity of the ADSC
Based on the results pertaining cell viability presented in Figure 1, we decided to measure
oxidative activity of mitochondria by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
(MTT) assay. After 24 h, the AmB-Cu2+ treatment caused a statistically significant increase of
mitochondrial oxidative activity comparing to the control (p = 0.0200), as well as cells exposed to AmB
(p = 0.0049) and PS-AmB-Cu2+ (p = 0.0034) (Figure 2A).
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Figure 2. Cell viability based on the measurement of mitochondrial oxidative activity after exposure to
the tested antibiotics and their combinations for 24 (A), 48 (B) and 72 h (C). The bars represent the means
± standard deviation (SD) of the percentages of the control cell viability (100%); ANOVA with the Tukey
post hoc test, * p < 0.05 vs. the control, # p < 0.05 vs. PS, ˆ p < 0.05 vs. AmB-Cu2+, + p < 0.05 vs. AmB,
$ p < 0.05 vs. PS-AmB-Cu2+.
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48 h exposure caused significant increase of mitochondrial activity of cells treated with AmB-Cu2+
and PS-AmB in comparison to control (p = 0.0334, p = 0.0001), PS (p = 0.0045, p = 0.0001) and AmB group
(p = 0.0073, p = 0.0001) (Figure 2B). Moreover, mitochondrial activity of PS-AmB-Cu2+-treated cells was
significantly higher than that measured for AmB and PS-treated cells (p = 0.0308 and p = 0.0047, respectively).
After 72 h, the cells that were exposed to AmB and PS-AmB showed a significant increase in cell
viability compared to the control, PS-, AmB-Cu2+-, and PS-AmB-Cu2+-treated cells (p < 0.0080 in all
comparisons) (Figure 2C). Viability was also significantly increased in cells treated with PS-AmB-Cu2+
comparing to the control and cells exposed to PS (p < 0.0030 in both comparisons) (Figure 2C).
2.3. Impact of Antibiotics on the Mesenchymal Stem Cells Markers
Besides direct effects on cell viability, antibiotics may also affect the stemness phenotype of ADSC.
Hence, we have assessed how the tested combinations of antibiotics may affect the expression of
mesenchymal stem cell markers like CD73, CD90, and CD105, both at mRNA and protein level.
None of the tested drugs or their combinations has changed the expression of CD90 mRNA in
comparison to control. AmB caused significantly lower mRNA expression of CD90 marker compared
to PS (p = 0.0086).
AmB caused also decrease of CD73 mRNA level comparing to control, PS-, AmB-Cu2+-,
and PS-AmB-treated cells (p = 0.0063, p = 0.0002, p = 0.0098, p = 0.0016, respectively) (Figure 3).
CD105 mRNA expression was statistically significantly higher after treatment with PS comparing
to control, AmB-, AmB-Cu2+-, PS-AmB- and PS-AmB-Cu2+-treated cells (p = 0.0002, p = 0.0001,
p = 0.0008, p = 0.0136, p = 0.0331, respectively). AmB caused decrease of CD105 mRNA level comparing
PS-AmB-Cu2+ (p = 0.0100).
Fluorescence-activated cell sorting (FACS) analysis showed the presence of CD73, CD90 and
CD105 markers at protein level in all analyzed groups. The percentage of marker-positive cells was
slightly higher after treatment with antibiotics (Figure 4).
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Figure 3. The mRNA levels of MSC markers CD73, CD90 and CD105 in the ADSC after exposure to the
tested antibiotic combinations (RT-qPCR analysis). The bars represent the means ± standard deviation
(SD) of the copy numbers per 1 µg of total RNA; ANOVA with the Tukey post hoc test, * p < 0.05 vs. control,
# p< 0.05 vs. PS, ˆ p< 0.05 vs. AmB-Cu2+, + p< 0.05 vs. AmB, & p< 0.05 vs. PS-AmB, $ p< 0.05 vs. PS-AmB-Cu2+.
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Figure 4. The percentage of positive cells for CD73, CD90 and CD105 markers after treatment with
tested antibiotic and their combinations (FACS analysis).
We also analyzed the morphology of the adipose-derived stem cells after 14 days (Figure 5).
We did not observe any essential differences because all of the cells retained their fibroblast-like shape.
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Figure 5. The morphology of the ADSC after exposure to the tested combinations of antibiotics.
ADSC were exposed for 14 days to AmB (B), AmB-Cu2+ (C), PS (D), PS-AmB (E) and PS-AmB-Cu2+
(F), and compared to the control cells (A).
2.4. Impact of Antibiotics on Adipogenesis
Antibiotics may also induce differentiati n towards certain lin age commitm nts. Hence,
to examine that possibility, cells were cultured for 14 days in standard medium without dedicated
factors stimulating adipogenesis. We have analyzed adipogenesis markers—HOXC8 (Figure 6A) and
LEP genes (Figure 6B)—at the mRNA level using RT-qPCR.
The expression of HOXC8 gene was increased after exposure to PS and PS-AmB-Cu2+, compared to
the control (p = 0.0071 and p = 0.0067, respectively). In AmB-treated cells, the expression of this marker
was significantly lower comparing to PS, AmB-Cu2+ and PS-AmB-Cu2+ (p = 0.0012, p = 0.0426 and
p = 0.0010, respectively).
The level of LEP mRNA was significantly higher in cells exposed to PS in comparison t control,
AmB-, AmB-Cu2+-, and PS-AmB-treated cells (p = 0.0005, p = 0.0001, p = 0.0094, and p = 0.0150,
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accordingly). Additionally, in cells treated with AmB, the LEP mRNA level was significantly lower
than in PS-AmB-Cu2+-treated cells (p = 0.0053).
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the means ± standard deviation (SD) of the copy numbers per 1 µg of total RNA; ANOVA with the
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The Oil Red O showed very weak staining of lipids in control cells and slightly stronger staining
in cells treated with PS-AmB-Cu2+ (Figure 7). The optical density (OD) value was the highest for
PS-AmB-Cu2+-treated cells (OD = 0.65).
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PS-AmB (E) and PS-AmB-Cu2+ (F), and compared to the control cells (A).
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2.5. Impact of Antibiotics on Nonstimulated Osteogenesis
To investigate possible effects of the tested combinations of antibiotics towards osteoblastic
differentiation, we have assessed the changes in the expression of osteoblastic markers (BGLAP,
RUNX2, ALP and SPP1 mRNAs) by RT-qPCR. The ADSC were cultured for 14 days in standard
Dulbecco’s Modified Eagle Medium (DMEM) without dedicated factors stimulating osteoblastic
differentiation. The changes in the expression of osteoblast markers BGLAP and RUNX2 were similar
in studied groups (Figure 8). ALP and SPP1 mRNA was not detectable in analyzed groups.
The expression of RUNX2 was significantly higher in cells treated with PS, AmB-Cu2+ and
PS-AmB in comparison to control (accordingly: p = 0.00003, p = 0.0110, p = 0.0005). AmB caused
downregulation of this marker in comparison to PS-, AmB-Cu2+- and PS-AmB-treated cells (p = 0.0014,
p = 0.0279, p = 0.0020, respectively).
BGLAP mRNA level was higher in PS-treated cells comparing to control (p = 0.0079). After AmB
treatment, the expression of BGLAP was lower in comparison to groups: PS, PS-AmB and PS-AmB-Cu2+
(p = 0.0002, p = 0.0181, p = 0.0008, respectively).
Alizarin Red staining showed slight increase of extracellular calcium in the groups of cells treated
with AmB-Cu2+, PS and PS-AmB (Figure 9). However, significant difference was statistically confirmed
only in the comparison between AmB-Cu2+ and PS-AmB-Cu2+ groups (p = 0.0380).
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Figure 8. The mRNA levels of osteoblastic markers BGLAP and RUNX2 in the ADSC after exposure
to the tested antibiotic combinations. The bars represent the means ± standard deviation (SD) of the
copy numbers per 1 µg of total RNA; ANOVA with the Tukey post hoc test, * p < 0.05 vs. control,
+ p < 0.05 vs. AmB, ˆ p < 0.05 vs. AmB-Cu2+.
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Figure 9. Alizarin Red staining of extracellular calcium after exposure of ADSC to the tested
combinations of antibiotics. ADSC were exposed for 14 day to AmB (B), AmB-Cu2+ (C), PS (D),
PS-AmB (E) and PS-AmB-Cu2+ (F), and compared to the control cells (A).
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2.6. Impact of Antibiotics on Osteogenesis in the Presence of Pro-Osteogenic Factors
Following the results shown above, we decided to perform follow-up experiments to test if/how
the tested antibiotics affect stimulated osteogenic differentiation. To induce osteoblastic differentiation,
the ADSC were cultured for 14 days in a DMEM medium supplemented with factors that stimulate
osteogenesis (L-ascorbic acid 2-phosphate, dexamethasone and β-glycerophosphate) and combinations
of tested antibiotics (Figure 10).
Expression of BGLAP mRNA did not differ in comparison to the control. However, there was
statistically significantly higher expression in AmB- (p = 0.0023) and in AmB-Cu2+- (p = 0.0091)
compared to PS-treated cells.
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Figure 10. The mRNA levels of osteogenic markers BGLAP, RUNX2, SPP1 and ALP in the ADSC after
exposure of ADSC to the tested combinations of antibiotics. The bars represent the (Me) with the
25th and 75th quartiles and the minimum and maximum of the copy numbers per 1 µg of total RNA;
the Kruskal–Wallis test with post hoc was applied to assess any differences in the expression of the
genes, * p < 0.05 vs. control, ˆ p < 0.05 vs. AmB-Cu2+, # p < 0.05 vs. PS, $ p < 0.05 vs. PS-AmB-Cu2+.
The mRNA level of RUNX2 was significantly lower in cells treated with AmB and AmB-Cu2+
compared to the control (p = 0.0019 and p = 0.0002) and PS-treated cells (p = 0.0134 and p = 0.0016).
Moreover, the RUNX2 expression in AmB-Cu2+ was significantly lower than in cells treated with
PS-AmB-Cu2+ (p = 0.0154).
SPP1 mRNA showed a statistically significantly lower expression in groups: AmB (p = 0.0002),
AmB-Cu2+ (p = 0.0033) and PS-AmB (p = 0.0334), compared to control. There was also a statistically
significantly lower expression of this marker in AmB- (p = 0.0005226) and AmB-Cu2+ groups
(p = 0.008530) in comparison to PS-AmB-Cu2+-treated cells.
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No statistically significant difference was observed in the expression of ALP in the examined
groups in comparison to control cells. The expression of ALP was significantly higher in AmB-treated
cells compared to group PS (p = 0.0123).
For osteogenesis, the presence of extracellular calcium was confirmed by Alizarin Red staining.
As shown in Figure 11, the presence of extracellular calcium was observed in all of the groups of cells.
A lower level of calcium content was noticed for cells treated with PS and PS-AmB-Cu2+ compared
to control (p = 0.0001 and p = 0.0002). Calcium level was significantly higher for cells treated with
AmB in comparison to control cells (p = 0.0015) and cells treated with PS (p = 0.0001), PS-AmB
(p = 0.0030), and PS-AmB-Cu2+ (p = 0.0001). AmB-Cu2+ and PS-AmB caused increase of calcium
content in comparison to PS- (p = 0.0001 and p = 0.0001) and PS-AmB-Cu2+-treated cells (p = 0.0001
and p = 0.0007).
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Figure 11. The lizarin Red staining in the ADSC after exposure to the osteogenesis medium with
the addition of AmB (B), AmB-Cu2+ (C), PS (D), PS-AmB (E) and PS-AmB-Cu2+ (F) compared to the
control cells (A).
3. Discussion
Mesenchymal stem cells (MSC) are multipotent, somatic cells with multilineage differentiation
ability. Furthermore, they also have immunomodulatory, angiogenic and antiapoptotic activities
through the secretion of growth factors, cytokines and peptides. MSC can be isolated from bone
marrow, skin, whole blood or adipose tissue. ADSC have many advantages such as a low risk of
side effects when being harvested and the fact that the tissue is easy to obtain from almost every
patient, or from medical waste upon cosmetic surgeries; hence there are no ethical issues. Moreover,
the cells are easy to culture and they can differentiate into adipocytes, chondrocytes, osteoblasts and
myocytes [2,5,6,8,20].
Many endogenous and exogenous factors may affect the proliferation and differentiation ability of
mesenchymal stem cells, e.g., derivation of adipose tissue, age of donors, comorbidities, method used
to isolate the stem cells, as well as the duration and conditions of culturing them [20,21]. The role of
the antibiotics is to prevent any contamination of the cell culture. However, it is necessary to only use
them temporarily because longer exposures may lead to important phenotype changes. Additionally,
some antibiotics and especially antimycotics can also be cytotoxic. Cohen et al. proved, for example,
that gentamycin and penicillin-streptomycin inhibit the growth of embryonic stem cells [13].
Moreover, all methods of nonisogenic transplantation require the use of immunosuppressive
agents, which induces a temporary immune deficiency, often facilitating dangerous fungal infections.
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The types of antifungal drugs that are used depend on an individual’s symptoms, concurrent illnesses
and the species of fungi [10,22]. The main groups of antifungal drugs that are used in patients with
hematopoietic stem cell transplantations are azoles such as fluconazole, echinocandins and polyenes,
e.g., different forms of amphotericin B (AmB), a drug that is also most often used to prevent a fungal
contamination in a cell culture. Antifungal activities are arising from the inhibition of the synthesis of
nucleic acids due to their effect on the ergosterol in the liquid membrane [10,22]. Unfortunately, AmB’s
clinical use is limited by its strong nephrotoxic properties [23]. The mechanism of the nephrotoxicity
of AmB is not well-known. It is possibly connected to the formation of pores and the destabilization of
the cell membrane [15,23,24]. Furthermore, AmB induces the expression of cytokines and chemokines
that are involved in destroying the kidneys, e.g., a higher expression of interleukin 1β, TNFα, IL-6 and
IL-8 [24]. The aim of many studies has been the creation of a new form of amphotericin B, e.g., such as
a lipid complex or liposomal and colloid forms [10,24–26], to counteract its limitations. A recently
developed complex of amphotericin B with copper (II) ions possess high antifungal properties and is
less toxic to animal cells than AmB [16–18]. However, its activity on MSC has not been studied so far.
To gain better understanding of the used experimental systems in regenerative medicine and
tissue engineering, we have evaluated the effect of antibiotics on the growth and differentiation of
the MSC derived from the adipose tissue commonly used in cell culture settings and in the clinic.
Additionally, previous studies reporting lower toxicity of AmB-Cu2+ on human proximal tubular
epithelial cells (RPTEC) and fibroblasts encouraged us to assess also its influence on mesenchymal
stem cells [17,18].
Our experiments examined the short- and long-term effects of antibiotics and antimycotics.
The concentrations of penicillin-streptomycin were determined based on literature data [10,11].
In a previous study, it was proven that 0.5 µg/mL of AmB and AmB-Cu2+ did not inhibit the
growth of RPTECs [18]. This concentration was selected as suitable for the analysis. It is also the
most often used concentration of AmB in cell cultures of mesenchymal stem cells, especially for
adipose-derived stem cells, according to the literature. Initially, we analyzed the influence of antibiotics
and antimycotics on the growth of adipose-derived stem cells. The addition of antibiotics adversely
affected cell growth within 24 h. Similar results were obtained by others while testing the effects of
rifampicin and chloramphenicol [27]. Both antibiotics reduced the cell growth in limbal stem cells [27].
We however did not observe any substantial inhibition of the mitochondrial activity using an MTT
assay; surprisingly, there was higher mitochondrial activity in the cells after exposure to AmB-Cu2+.
After 48 h, we observed similar results in both assays (cell growth SRB—sulforhodamine B and MTT),
and the highest proliferation of the cells occurred in the group that was treated with AmB-Cu2+.
After 72 h however, an inhibition of protein production and mitochondrial activity was detected in
the cells after exposure to AmB-Cu2+ compared to AmB alone. As the first days of the experiment
caused an increased proliferation, the decrease observed after 72 h may be the result of the rapid
depletion of nutrients in the culture medium of cell treated with AmB-Cu2+. In turn, observed increase
of cells viability after 72 h of incubation with AmB may indicate that MSC inactivated this drug only
after two days. Thus, we conclude that MSC tolerate the exposure to AmB-Cu2+ much better than
AmB. Our finding in these assays indicates that the cellular changes depend on the time of exposure
and type, as well as combination of antibiotics used in the experiment. Some discrepancies observed
between the read-outs from SRB and from the MTT assay reflect the fact that both assays measure
different cellular parameters.
We have also made some interesting observations regarding the effects of tested combinations of
antibiotics on the maintenance of MSC phenotype, as assessed by the expression of various stemnesses
and differentiation markers. ADSC were cultivated in standard medium without factors stimulating
differentiation into adipocytes or osteocytes. We noticed a slight increase of population of cells
coexpressing MSC markers under exposure to tested drugs. However, AmB caused a decrease of MSC
markers at mRNA level. This may result from the influence of amphotericin B on mRNA stability.
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To assess potential adipogenic differentiation, we measured the expression (RT-qPCR) of HOXC8
(homebox 8) and LEP (leptin) genes. These genes are characteristic for white adipose tissue cells [28].
To some degree, all the combinations of tested antibiotics, except AmB, did increase the expressions
of LEP and HOCX8, most significantly the penicillin-streptomycin. However, lipid staining with Oil
Red O resulted in a weak signal, except for cells treated with PS-AmB-Cu2+. Hence, the addition of
PS may be beneficial in supporting adipogenic differentiation in desirable medical settings. On the
other hand, some studies have proved that PS may be cytotoxic to embryonic stem cells. Furthermore,
Zur Nieden and colleagues have reported that penicillin G inhibited the differentiation of embryonic
stem cells into osteocytes and chondrocytes [29]. Thus, we assessed also the influence of tested drugs
on osteogenesis.
All antibiotics, except AmB, caused an increase of RUNX2 and BGLAP mRNA level. We did
not detect the mRNA of ALP and SPP1. However, the staining with Alizarin Red revealed
the presence of extracellular calcium content, therefore we decided to evaluate the influence
of tested drugs on osteogenesis in the presence of dedicated factors stimulating this process.
We observed significant differences between amphotericin B and penicillin-streptomycin on the
induction of osteogenesis. This study showed that amphotericin B and its new form with
copper ions did produce significant effects of the osteogenesis, especially the lower expression of
RUNX2, which is an early marker of osteogenesis and the osteopontin (SPP1) gene, which is a late
marker of osteogenesis. Interestingly, we did observed a higher expression of the gene coding
osteocalcin (BGLAP), which is a medium marker of osteogenesis. Hence, we can assume that
amphotericin B and AmB-Cu2+ influence osteogenesis in the presence of osteogenesis-induction
factors, including dexamethasone, β-glycerophosphate and L-ascorbic acid. The combination of
AmB or AmB-Cu2+ with penicillin-streptomycin markedly modulated the expression of osteogenesis
markers. Alizarin Red staining confirmed that AmB promoted osteogenesis, while addition of
penicillin-streptomycin caused weaker signal. The mechanism of the action of streptomycin is
connected to its binding to the 30S subunit of the bacterial ribosome. However, it also possesses
some affinity to the ribosomes in eukaryotic cells. Relier and colleagues suggested that streptomycin
may act on eukaryotic cells through the disruption of protein synthesis, by affecting mitochondrial
activity, by binding to certain RNAs or by interfering with miRNAs action [12]. This indicates
that the addition of streptomycin changes the gene expression profile in cells and it may affect the
differentiation process.
4. Material and Methods
4.1. Cell Culture
Normal human adipose-derived stem cells (ADSC) (PT-5006; Lonza, Basel, Switzerland) were
routinely maintained in a DMEM medium (Dulbecco’s Modified Eagle Medium, Lonza, Basel,
Switzerland), which was supplemented with fetal bovine serum (FBS, EuroClone, Pero, Italy), at 37 ◦C
in a 5% CO2 incubator (Direct Heat CO2; Thermo Fisher Scientific, Waltham, MA, USA). The ADSC
that were used for the experiment were at second passage.
4.2. Exposure of Cells to Antibiotics
The cells were treated with 0.5 µg/mL of amphotericin B (AmB) (Sigma-Aldrich, St. Louis, MO,
USA), 0.5 µg/mL of amphotericin B complex with copper ions (AmB-Cu2+) [16,30], 10 µL/mL of
penicillin-streptomycin complex (PS) (100 IU/mL for penicillin and 100 µg/mL for streptomycin)
(Lonza) or combinations of these—amphotericin B with penicillin-streptomycin (PS-AmB) and the
AmB-Cu2+ with penicillin streptomycin (PS-AmB-Cu2+). Control cells were cultured in a medium
without antibiotics.
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4.3. Sulforhodamine B Assay
The cells were seeded into a 96-well culture plate at a density of 5× 103 cells per well. The cellular
protein content in the cells after exposure to antibiotics was tested using a Sulforhodamine B
(SRB)-based in vitro toxicology assay kit (TOX6, Sigma-Aldrich, St Louis, MO, USA) and a Wallac 1420
VICTOR plate reader (Perkin Elmer, Waltham, MA, USA) according to the manufacturer’s instructions.
The total cellular protein content in the cells was measured after 24 h, 48 h and 72 h of exposure.
4.4. MTT Assay
For the cytotoxicity assay, the cells were seeded into a 96-well culture plate at a density of
5 × 103 cells per well. MTT-assay was performed similarly as described recently [31]. Briefly,
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) (Sigma-Aldrich, St. Louis, MO,
USA) conversion was used to evaluate the metabolic activity of the cells after their exposure to
antibiotics, according to the manufacturer’s instructions. Absorbance was measured using Wallac 1420
VICTOR plate reader (Perkin Elmer, Waltham, MA, USA). The mitochondrial activity of the cells was
measured after 24 h, 48 h and 72 h of exposure.
4.5. Quantitative Real-Time Polymerase Chain Reaction Assay
Total RNA was extracted from the cells using a TRIzol reagent (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer’s instructions. The nucleic acid concentration was determined using
a MaestroNano Spectrophotometer (Maestrogen, Hsinchu City, Taiwan). The expression mRNAs
was detected using the real time RT-qPCR technique with SYBR Green chemistry (SYBR Green
Quantitect RT-PCR Kit, Qiagen, Hilden, Germany) and an Opticon™ DNA Engine Continuous
Fluorescence detector (MJ Research Inc., Waltham, MA, USA) as was previously described [32].
All of the samples were tested in triplicate. β-actin was included as an endogenous positive control
(housekeeping/structural gene) of the amplification and the integrity of the extracts. Oligonucleotide
primers were purchased from the Sigma Aldrich Company (Sigma-Aldrich, St. Louis, MO, USA).
Each run was completed using a melting curve analysis to confirm the specificity of the amplification
and the absence of primer dimers. The RT-qPCR products were separated on 6% polyacrylamide
gels and visualized using silver salts. To quantify the results for the products that were obtained by
RT-qPCR, the standard curve method was used as was previously described [32].
4.6. Mesenchymal Stem Cells Markers Analysis
Cells were cultured for 14 days in medium without any differentiation factors in the presence
of tested antibiotics and their combinations. Control cells were cultured in the medium without
antibiotics. Cells were collected to the RT-qPCR analysis and for flow cytometry analysis (CD73,
CD90, CD105). R&D Systems Human Mesenchymal Stem Cell Marker Verification Multi-Color Flow
Cytometry Kit (R&D Systems, Minneapolis, MN, USA) was used for mesenchymal stem cells markers
identification: CD73-CFS, CD90-APC, CD105-PerCP. Cell fluorescence was measured immediately
after staining (FACS Aria 2; Becton Dickinson, Franklin Lakes, NJ, USA), and data were analyzed
using software (Becton Dickinson, Franklin Lakes, NJ, USA) measured as the percentile of gated cells
in fluorescent channels with activities of the corresponding isotype controls.
4.7. Adipocyte Differentiation Analysis without Differentiation Factors
After 14 days of culture, the Oil Red O staining and RT-qPCR analysis of HOX2 and LEP mRNAs
was performed.
Oil Red O staining is a microscopic visualization of the lipid droplets that are characteristic
structures for adipocytes. For quantification of staining after washing out unbound dye and extraction
with the isopropanol from cells, spectrophotometric analysis for quantitative assessment was carried
out. The obtained absorbance value was calculated based on a calibration curve prepared with a series
Int. J. Mol. Sci. 2017, 18, 2522 14 of 18
of Oil Red O solutions of known concentrations. The OD of supernatants was read at 405 nm in 96-well
plate using a Perkin Elmer Wallac VICTOR2.
4.8. Osteoblast Differentiation Analysis without Differentiation Factors
After 14 days of cell culture without any differentiation factors, Alizarin Red staining and RT-qPCR
analysis (BGLAP, RUNX2, ALP, SPP1 mRNAs) was performed.
Alizarin Red staining was used to evaluate calcium deposits in the culture by the cells.
Alizarin Red at a concentration 40 mM was prepared in ddH2O and the pH was adjusted to
4.2 using 10% ammonium hydroxide. The assayed cells were washed with phosphate buffered
saline (PBS) and fixed in 70% ethanol (Sigma-Aldrich, St Louis, MO, USA). Next, the monolayers
were washed twice with dH2O and then Alizarin Red S was added. The plates were incubated
at room temperature for 30 min with shaking. Stained cells were visualized using an Olympus
IX81 microscope (Shinjuku, Tokyo, Japan) and a DP70 camera (Olympus, Shinjuku, Tokyo, Japan)
was used for the photographic documentation. To quantify the staining, the acetic acid
(Sigma-Aldrich, St Louis, MO, USA) method was applied to recover the stain from calcium deposits.
Stain solutions were adjusted to pH 4.2 with ammonium hydroxide and samples were read at 405 nm
in a 96-well plate using a Perkin Elmer Wallac VICTOR2.
4.9. Osteoblast Differentiation Analysis in the Presence of Differentiation Factors
Next, the cells were plated and grown until there was 80% of the confluent after which
the medium was replaced with a fresh DMEM medium with fetal bovine serum (FBS) and
0.2 mM L-ascorbic acid 2-phosphate, 107 M dexamethasone and 10 mM β-glycerophosphate
(Sigma-Aldrich, St Louis, MO, USA). Cells were cultured in the above-described media with or
without antibiotics for another 14 days. After 14 days, the cells were collected and the Alizarin
S red staining and RT-qPCR analysis (BGLAP, RUNX2, ALP, SPP1 mRNAs) was performed.
4.10. Statistical Analysis
Statistical analysis was performed using Statistica 13.0 software (StatSoft, Tulsa, OK, USA).
The values are expressed as the means and standard deviation (SD) for normally distributed data.
A one-way ANOVA test and a Tukey’s post hoc test were applied to evaluate any differences in the
examined groups. For the non-normally distributed data, values were expressed as median value (Me)
with the 25th and 75th quartiles and the Mann–Whitney U test was applied to assess differences in the
expression of genes. Differences between the different groups were compared using Kruskal–Wallis
test. The level of significance was set at p < 0.05 for all of the statistical tests.
5. Conclusions
In summary, our results suggest that the presence of the antibiotics that are commonly used
in cell cultures is not completely neutral to the phenotype of ADSC. Moreover, they modulate the
differentiation process. Both AmB and AmB-Cu2+ as well as their combinations with PS affect the level
of differentiation markers, however AmB-Cu2+ is better tolerated by stem cells. Antibiotics should
probably only be used in special situations such as the isolation of a cell from a biopsy and at the early
stages of a culture after which a standard culture should be done without this addition. Finally, it would
be advised to choose the combination of antibiotics and antimycotics with caution, in a more targeted
fashion, when propagating ADSC and possibly also other cell types. The findings are especially
important given a rapid increase of experimental use of stem cells, in particular induced-pluripotent
stem cells (iPS), and MSC (often ADSC), in the development of various regenerative medicine
techniques [33–35]. Rapid development of direct transdifferentiation techniques, which bypass the
stage/use of stem cells [1,36–38], is another area where the presented in this manuscript results may
be of key importance for the optimal results.
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Abbreviations
ADSC adipose-derived stem cells
ALP alkaline phosphatase
AmB amphotericin B
AmB Cu2+-complex of AmB with copper(II) ions
ANOVA analysis of variance
ATCC American Type Culture Collection
BGLAP osteocalcin
bis-AAF-R110 bis-alanyl-alanyl-phenylalanyl-rhodamine 110
CD105 Endoglin
CD73 cluster of differentiation 73/ecto-5′-nucleotidase
CD90 cluster differentiation 90/Thy-1 antigen
dH2O distilled water
DMEM Dulbecco’s Modified Eagle Medium
FBS fetal bovine serum
GF-AFC glycyl-phenylalanyl-aminofluorocoumarin
HOXC8 homebox 8
IL-6 interleukin 6
IL-8 interleukin 8
LEP leptin
mRNA messenger ribonucleic acid
MSC mesenchymal stem cells
MTT 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
PBS phosphate buffered saline
PS penicillin-streptomycin complex
PS-AmB amphotericin B with penicillin-streptomycin
PS-AmB-Cu2+ amphotericin B complex with copper (II) ions with penicillin streptomycin
RFU relative fluorescence units
RLU relative luminescence units
ROS reactive oxygen species
RTq PCR quantitative real-time polymerase chain reaction
RUNX2 runt-related transcription factor 2
SPP1 osteopontin
SRB sulforhodamine B
SVF stromal vascular fraction
TNFα tumor necrosis factor α.
References
1. Cieslar-Pobuda, A.; Knoflach, V.; Ringh, M.V.; Stark, J.; Likus, W.; Siemianowicz, K.; Ghavami, S.; Hudecki, A.;
Green, J.L.; Los, M.J. Transdifferentiation and reprogramming: Overview of the processes, their similarities
and differences. Biochim. Biophys. Acta 2017, 1864, 1359–1369. [CrossRef] [PubMed]
Int. J. Mol. Sci. 2017, 18, 2522 16 of 18
2. Baglioni, S.; Francalanci, M.; Squecco, R.; Lombardi, A.; Cantini, G.; Angeli, R.; Gelmini, S.; Guasti, D.;
Benvenuti, S.; Annunziato, F.; et al. Characterization of human adult stem-cell populations isolated from
visceral and subcutaneous adipose tissue. FASEB J. 2009, 23, 3494–3505. [CrossRef] [PubMed]
3. Mohammadi, Z.; Afshari, J.T.; Keramati, M.R.; Alamdari, D.H.; Ganjibakhsh, M.; Zarmehri, A.M.; Jangjoo, A.;
Sadeghian, M.H.; Ameri, M.A.; Moinzadeh, L. Differentiation of adipocytes and osteocytes from human
adipose and placental mesenchymal stem cells. Iran. J. Basic Med. Sci. 2015, 18, 259. [PubMed]
4. Romanov, Y.A.; Darevskaya, A.N.; Merzlikina, N.V.; Buravkova, L.B. Mesenchymal stem cells from human
bone marrow and adipose tissue: Isolation, characterization, and differentiation potentialities. Bull. Exp.
Biol. Med. 2005, 140, 138–143. [CrossRef] [PubMed]
5. Bunnell, B.A.; Flaat, M.; Gagliardi, C.; Patel, B.; Ripoll, C. Adipose-derived stem cells: Isolation,
expansion and differentiation. Methods 2008, 45, 115–120. [CrossRef] [PubMed]
6. Lee, A.-Y.; Lee, J.; Kim, C.-L.; Lee, K.S.; Lee, S.-H.; Gu, N.-Y.; Kim, J.-M.; Lee, B.C.; Koo, O.J.; Song, J.-Y.; et al.
Comparative studies on proliferation, molecular markers and differentiation potential of mesenchymal stem
cells from various tissues (adipose, bone marrow, ear skin, abdominal skin, and lung) and maintenance of
multipotency during serial passages in miniature pig. Res. Vet. Sci. 2015, 100, 115–124. [CrossRef] [PubMed]
7. Watson, J.E.; Patel, N.A.; Carter, G.; Moor, A.; Patel, R.; Ghansah, T.; Mathur, A.; Murr, M.M.; Bickford, P.;
Gould, L.J.; et al. Comparison of Markers and Functional Attributes of Human Adipose-Derived Stem Cells
and Dedifferentiated Adipocyte Cells from Subcutaneous Fat of an Obese Diabetic Donor. Adv. Wound Care
2014, 3, 219–228. [CrossRef] [PubMed]
8. Buehrer, B.M.; Cheatham, B. Isolation and characterization of human adipose-derived stem cells for use in
tissue engineering. Methods Mol. Biol. 2013, 1001, 1–11. [CrossRef] [PubMed]
9. Christodoulou, I.; Kolisis, F.N.; Papaevangeliou, D.; Zoumpourlis, V. Comparative Evaluation of Human
Mesenchymal Stem Cells of Fetal (Wharton’s Jelly) and Adult (Adipose Tissue) Origin during Prolonged In
Vitro Expansion: Considerations for Cytotherapy. Stem Cells Int. 2013, 2013, 1–12. [CrossRef] [PubMed]
10. Busca, A.; Pagano, L. Antifungal therapy in hematopoietic stem cell transplant recipients. Mediterr. J. Hematol.
Infect. Dis. 2016, 8, e2016039. [CrossRef] [PubMed]
11. Chen, Y.-J.; Liu, H.-Y.; Chang, Y.-T.; Cheng, Y.-H.; Mersmann, H.J.; Kuo, W.-H.; Ding, S.-T. Isolation and
Differentiation of Adipose-Derived Stem Cells from Porcine Subcutaneous Adipose Tissues. J. Vis. Exp. 2016.
[CrossRef] [PubMed]
12. Relier, S.; Yazdani, L.; Ayad, O.; Choquet, A.; Bourgaux, J.-F.; Prudhomme, M.; Pannequin, J.; Macari, F.;
David, A. Antibiotics inhibit sphere-forming ability in suspension culture. Cancer Cell Int. 2016, 16. [CrossRef]
[PubMed]
13. Cohen, S.; Samadikuchaksaraei, A.; Polak, J.M.; Bishop, A.E. Antibiotics reduce the growth rate and
differentiation of embryonic stem cell cultures. Tissue Eng. 2006, 12, 2025–2030. [CrossRef] [PubMed]
14. Mathieson, W.; Kirkland, S.; Leonard, R.; Thomas, G.A. Antimicrobials and in vitro systems: Antibiotics and
antimycotics alter the proteome of MCF-7 cells in culture. J. Cell. Biochem. 2011, 112, 2170–2178. [CrossRef]
[PubMed]
15. Mesa-Arango, A.C.; Scorzoni, L.; Zaragoza, O. It only takes one to do many jobs: Amphotericin B as
antifungal and immunomodulatory drug. Front. Microbiol. 2012, 3. [CrossRef] [PubMed]
16. Chudzik, B.; Tracz, I.B.; Czernel, G.; Fiołka, M.J.; Borsuk, G.; Gagos´, M. Amphotericin B–copper(II) complex
as a potential agent with higher antifungal activity against Candida albicans. Eur. J. Pharm. Sci. 2013,
49, 850–857. [CrossRef] [PubMed]
17. Chudzik, B.; Czernel, G.; Miaskowski, A.; Gagos, M. Amphotericin B-copper(II) complex shows improved
therapeutic index in vitro. Eur. J. Pharm. Sci. 2017, 97, 9–21. [CrossRef] [PubMed]
18. Gola, J.; Skubis, A.; Sikora, B.; Kruszniewska-Rajs, C.; Adamska, J.; Mazurek, U.; Strzałka-Mrozik, B.;
Czernel, G.; Gagos´, M. Expression profiles of genes related to melatonin and oxidative stress in human
renal proximal tubule cells treated with antibiotic amphotericin B and its modified forms. Turk. J. Biol. 2015,
39, 856–864. [CrossRef]
19. Gola, J.; Strzałka-Mrozik, B.; Kruszniewska-Rajs, C.; Janiszewski, A.; Skowronek, B.; Gagos´, M.; Czernel, G.;
Mazurek, U. A new form of amphotericin B—The complex with copper (II) ions—Downregulates sTNFR1
shedding and changes the activity of genes involved in TNF-induced pathways. Pharmacol. Rep. 2017,
69, 22–28. [CrossRef] [PubMed]
Int. J. Mol. Sci. 2017, 18, 2522 17 of 18
20. Dai, R.; Wang, Z.; Samanipour, R.; Koo, K.; Kim, K. Adipose-Derived Stem Cells for Tissue Engineering and
Regenerative Medicine Applications. Stem Cells Int. 2016, 2016, 1–19. [CrossRef] [PubMed]
21. Gnanasegaran, N.; Govindasamy, V.; Musa, S.; Kasim, N.H.A. Different Isolation Methods Alter the Gene
Expression Profiling of Adipose Derived Stem Cells. Int. J. Med. Sci. 2014, 11, 391–403. [CrossRef] [PubMed]
22. Styczynski, J.; Czyzewski, K.; Wysocki, M.; Gryniewicz-Kwiatkowska, O.; Kolodziejczyk-Gietka, A.;
Salamonowicz, M.; Hutnik, L.; Zajac-Spychala, O.; Zaucha-Prazmo, A.; Chelmecka-Wiktorczyk, L.; et al.
Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem
cell transplantation compared to conventional anticancer therapy: A multicentre nationwide study.
Clin. Microbiol. Infect. 2016, 22, 179 e1–179 e10. [CrossRef]
23. Antonowicz-Juchniewicz, J.; Jodkowska, A.; Kwiecin´ska, D. Nefropatie wtórne w praktyce lekarza medycyny
pracy. II. Nefropatie wtórne w przebiegu stosowania s´ródkow leczniczych i diagnostycznych. Med. Pr. 2006,
57, 455–468. [PubMed]
24. Hamill, R.J. Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity. Drugs 2013,
73, 919–934. [CrossRef] [PubMed]
25. Falci, D.R.; da Rosa, F.B.; Pasqualotto, A.C. Comparison of nephrotoxicity associated to different lipid
formulations of amphotericin B: A real-life study. Mycoses 2015, 58, 104–112. [CrossRef] [PubMed]
26. Steimbach, L.M.; Tonin, F.S.; Virtuoso, S.; Borba, H.H.L.; Sanches, A.C.C.; Wiens, A.; Fernandez-Llimós, F.;
Pontarolo, R. Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and
meta-analysis. Mycoses 2017, 60, 146–154. [CrossRef] [PubMed]
27. Turani, M.; Banfalvi, G.; Peter, A.; Kukoricza, K.; Kiraly, G.; Talas, L.; Tanczos, B.; Dezso, B.; Nagy, G.;
Kemeny-Beke, A. Antibiotics delay in vitro human stem cell regrowth. Toxicol. In Vitro 2015, 29, 370–379.
[CrossRef] [PubMed]
28. Pisani, D.F. Differentiation of human adipose-derived stem cells into “brite” (brown-in-white) adipocytes.
Front. Endocrinol. 2011, 2. [CrossRef] [PubMed]
29. Zur Nieden, N.; Kempka, G.; Ahr, H. Molecular multiple endpoint embryonic stem cell test—A possible
approach to test for the teratogenic potential of compounds. Toxicol. Appl. Pharmacol. 2004, 194, 257–269.
[CrossRef] [PubMed]
30. Gagos, M.; Czernel, G.; Kaminski, D.M.; Kostro, K. Spectroscopic studies of amphotericin B-Cu2+ complexes.
Biometals 2011, 24, 915–922. [CrossRef] [PubMed]
31. Jain, M.V.; Shareef, A.; Likus, W.; Cieslar-Pobuda, A.; Ghavami, S.; Los, M.J. Inhibition of miR301 enhances
Akt-mediated cell proliferation by accumulation of PTEN in nucleus and its effects on cell-cycle regulatory
proteins. Oncotarget 2016, 7, 20953–20965. [CrossRef] [PubMed]
32. Strzalka, B.; Dorecka, M.; Stanik-Walentek, A.; Kowalczyk, M.; Kapral, M.; Romaniuk, W.; Mazurek, U.;
Swiatkowska, L. Quantitative Analysis of Transforming Growth Factor [beta] Isoforms mRNA in the Human
Corneal Epithelium. Folia Biol. (Praha) 2008, 54, 46. [PubMed]
33. Gelmi, A.; Cieslar-Pobuda, A.; de Muinck, E.; Los, M.; Rafat, M.; Jager, E.W. Direct Mechanical Stimulation of
Stem Cells: A Beating Electromechanically Active Scaffold for Cardiac Tissue Engineering. Adv. Healthc. Mater.
2016, 5, 1471–1480. [CrossRef] [PubMed]
34. Hombach-Klonisch, S.; Panigrahi, S.; Rashedi, I.; Seifert, A.; Alberti, E.; Pocar, P.; Kurpisz, M.;
Schulze-Osthoff, K.; Mackiewicz, A.; Los, M. Adult stem cells and their trans-differentiation
potential—Perspectives and therapeutic applications. J. Mol. Med. Berl. 2008, 86, 1301–1314. [CrossRef]
[PubMed]
35. Sherrell, P.C.; Cieslar-Pobuda, A.; Ejneby, M.S.; Sammalisto, L.; Gelmi, A.; de Muinck, E.; Brask, J.; Los, M.J.;
Rafat, M. Rational Design of a Conductive Collagen Heart Patch. Macromol. Biosci. 2017. [CrossRef]
[PubMed]
36. Cieslar-Pobuda, A.; Jain, M.V.; Kratz, G.; Rzeszowska-Wolny, J.; Ghavami, S.; Wiechec, E. The expression
pattern of PFKFB3 enzyme distinguishes between induced-pluripotent stem cells and cancer stem cells.
Oncotarget 2015, 6, 29753–29770. [CrossRef] [PubMed]
Int. J. Mol. Sci. 2017, 18, 2522 18 of 18
37. Cieslar-Pobuda, A.; Rafat, M.; Knoflach, V.; Skonieczna, M.; Hudecki, A.; Malecki, A.; Urasinska, E.;
Ghavami, S.; Los, M.J. Human induced pluripotent stem cell differentiation and direct transdifferentiation
into corneal epithelial-like cells. Oncotarget 2016, 7, 42314–42329. [CrossRef] [PubMed]
38. Wasik, A.M.; Grabarek, J.; Pantovic, A.; Cieslar-Pobuda, A.; Asgari, H.R.; Bundgaard-Nielsen, C.; Rafat, M.;
Dixon, I.M.; Ghavami, S.; Los, M.J. Reprogramming and carcinogenesis—Parallels and distinctions. Int. Rev.
Cell Mol. Biol. 2014, 308, 167–203. [CrossRef] [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
